Anagenics Limited (AN1.AX)

0.0090 -0.0010 (-10.00%) At close: 10:26AM AEST

Anagenics Limited

55 Clarence Street
Suite 204 Level 2
Sydney, NSW 2000
Australia
61 2 9221 6830
https://anagenics.com

Sector(s): Consumer Defensive
Industry: Household & Personal Products
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Karen Matthews	CEO & Director	19.17k	N/A	N/A
Mr. Matthew Dudek	Chief Financial & Governance Officer and Company Secretary	282.67k	N/A	N/A
Mr. Scott Mitchell Greasley	Executive Director	1.15M	N/A	N/A
Mr. Dominic Burg	Chief Operating Officer	N/A	N/A	N/A
Dr. Graham Robertson	Head of Research & Development	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names. The company also develops, manufactures, and markets beauty and wellness brands comprising Uspa and evolis. It offers its products through various channels, including clinics, retail stores, wholesale pharmacy and spa/salons, online ecommerce, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.

Corporate governance

Anagenics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.